Cabergoline, a dopamine agonist acting on pituitary D2 receptors, has been used in pituitary-dependent hypercortisolism to suppress ACTH secretion, though responses are inconsistent and resistance often develops [40]. This evidence concerns the gene POMC and adrenal gland hyperfunction.